Aim & Scope
The Asia-Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia Pacific region in relation to cancer treatment and care. The Journal publishes pre-clinical studies, translational research, clinical trials and epidemiological studies, describing new findings of clinical significance. Clinical studies, particularly prospectively designed clinical trials, are encouraged. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. [1]
2024
Overdiagnosis and overtreatment of ground-glass nodule-like lung cancer.
Asia-Pacific Journal of Clinical Oncology , 2024
XT Wen , HF Qiu , LL Ying , ... , CC Fan
Asia-Pacific Journal of Clinical Oncology , 2024
N Hitchen , A Shahnam , S Manoharan , ... , B Tran
Asia-Pacific Journal of Clinical Oncology , 2024
A novel exosome‐related prognostic risk model for thyroid cancer
J Qi , H Cheng , L Su , ... , F Cheng
Asia-Pacific Journal of Clinical Oncology , 2024
N Tuckey , JV Agteren , A Chur-Hansen , ... , M Iasiello
Asia-Pacific Journal of Clinical Oncology , 2024
Editorial Retractions, Expressions of Concern and External Notices
LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
Asia-Pacific Journal of Clinical Oncology2021 - VOLUME 17, ISSUE 3 pp 253-263.
10 30
No authors listed.
Asia-Pacific Journal of Clinical Oncology
2023 - VOLUME 19, ISSUE 6
0 1
PubPeer
2022 - VOLUME 2022, ISSUE 12
0 0
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)